US8222385B2 - Germ cell marker using fish vasa gene - Google Patents
Germ cell marker using fish vasa gene Download PDFInfo
- Publication number
- US8222385B2 US8222385B2 US12/532,304 US53230408A US8222385B2 US 8222385 B2 US8222385 B2 US 8222385B2 US 53230408 A US53230408 A US 53230408A US 8222385 B2 US8222385 B2 US 8222385B2
- Authority
- US
- United States
- Prior art keywords
- tuna
- fish
- germ cell
- protein
- dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active, expires
Links
- 241000251468 Actinopterygii Species 0.000 title claims abstract description 106
- 210000004602 germ cell Anatomy 0.000 title abstract description 109
- 101150089602 vasa gene Proteins 0.000 title abstract description 66
- 239000002771 cell marker Substances 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 120
- 102000004169 proteins and genes Human genes 0.000 claims description 96
- 239000002773 nucleotide Substances 0.000 claims description 69
- 125000003729 nucleotide group Chemical group 0.000 claims description 69
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 59
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 19
- 239000013598 vector Substances 0.000 claims description 14
- 238000000034 method Methods 0.000 abstract description 99
- 235000019688 fish Nutrition 0.000 abstract description 91
- 241000276618 Perciformes Species 0.000 abstract description 44
- 241000269820 Euthynnus affinis Species 0.000 abstract description 29
- 241000894007 species Species 0.000 abstract description 23
- 210000004336 spermatogonium Anatomy 0.000 abstract description 14
- 210000002380 oogonia Anatomy 0.000 abstract description 12
- 239000003550 marker Substances 0.000 abstract description 11
- 241001147168 Scomber australasicus Species 0.000 abstract description 8
- 241000736084 Scomber japonicus Species 0.000 abstract description 8
- 210000002149 gonad Anatomy 0.000 abstract description 7
- 230000012010 growth Effects 0.000 abstract description 6
- 238000009395 breeding Methods 0.000 abstract description 5
- 230000001488 breeding effect Effects 0.000 abstract description 5
- 238000012163 sequencing technique Methods 0.000 abstract description 2
- 210000001082 somatic cell Anatomy 0.000 abstract description 2
- 108020004414 DNA Proteins 0.000 description 112
- 241000269838 Thunnus thynnus Species 0.000 description 54
- 239000000523 sample Substances 0.000 description 34
- 241001596943 Nibea mitsukurii Species 0.000 description 30
- 101100263436 Drosophila melanogaster vas gene Proteins 0.000 description 26
- 101100049051 Penaeus vannamei vasa gene Proteins 0.000 description 26
- 238000007792 addition Methods 0.000 description 25
- 238000012217 deletion Methods 0.000 description 25
- 230000037430 deletion Effects 0.000 description 25
- 238000003780 insertion Methods 0.000 description 25
- 230000037431 insertion Effects 0.000 description 25
- 238000006467 substitution reaction Methods 0.000 description 25
- 210000004027 cell Anatomy 0.000 description 24
- 239000012634 fragment Substances 0.000 description 23
- 238000006243 chemical reaction Methods 0.000 description 18
- 238000007857 nested PCR Methods 0.000 description 17
- 108091008146 restriction endonucleases Proteins 0.000 description 17
- 150000001413 amino acids Chemical class 0.000 description 16
- 239000000243 solution Substances 0.000 description 16
- 238000001514 detection method Methods 0.000 description 15
- 108090000765 processed proteins & peptides Proteins 0.000 description 14
- 108020004999 messenger RNA Proteins 0.000 description 13
- 241000269821 Scombridae Species 0.000 description 12
- 210000001672 ovary Anatomy 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 210000001550 testis Anatomy 0.000 description 12
- 108020004518 RNA Probes Proteins 0.000 description 11
- 239000003391 RNA probe Substances 0.000 description 11
- 210000001519 tissue Anatomy 0.000 description 10
- 108091028043 Nucleic acid sequence Proteins 0.000 description 9
- 230000000295 complement effect Effects 0.000 description 9
- 235000013601 eggs Nutrition 0.000 description 9
- 238000009396 hybridization Methods 0.000 description 9
- 235000020640 mackerel Nutrition 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 9
- 239000013604 expression vector Substances 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 238000002054 transplantation Methods 0.000 description 7
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 6
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 6
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 210000004392 genitalia Anatomy 0.000 description 6
- 210000004907 gland Anatomy 0.000 description 6
- 238000007901 in situ hybridization Methods 0.000 description 6
- 230000000366 juvenile effect Effects 0.000 description 6
- 230000035800 maturation Effects 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 241000045653 Scombriformes Species 0.000 description 5
- 230000003321 amplification Effects 0.000 description 5
- 239000000427 antigen Substances 0.000 description 5
- 102000036639 antigens Human genes 0.000 description 5
- 108091007433 antigens Proteins 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 102000037865 fusion proteins Human genes 0.000 description 5
- 108020001507 fusion proteins Proteins 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 4
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 4
- 241000277275 Oncorhynchus mykiss Species 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- 239000005090 green fluorescent protein Substances 0.000 description 4
- 210000001161 mammalian embryo Anatomy 0.000 description 4
- 230000006798 recombination Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- -1 t-butyloxycarbonyl Chemical group 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 3
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 108091034117 Oligonucleotide Proteins 0.000 description 3
- 241001282110 Pagrus major Species 0.000 description 3
- 241000276615 Percoidei Species 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 238000000520 microinjection Methods 0.000 description 3
- 238000010369 molecular cloning Methods 0.000 description 3
- 238000002703 mutagenesis Methods 0.000 description 3
- 231100000350 mutagenesis Toxicity 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 238000002741 site-directed mutagenesis Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 241000549556 Nanos Species 0.000 description 2
- 241000277269 Oncorhynchus masou Species 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 101710136296 Probable ATP-dependent RNA helicase DDX4 Proteins 0.000 description 2
- 238000002105 Southern blotting Methods 0.000 description 2
- 241000269841 Thunnus albacares Species 0.000 description 2
- 241000212888 Thunnus tonggol Species 0.000 description 2
- 238000001042 affinity chromatography Methods 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000024245 cell differentiation Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 2
- SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 2
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
- 238000012407 engineering method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000004720 fertilization Effects 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 238000003505 heat denaturation Methods 0.000 description 2
- 210000004408 hybridoma Anatomy 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000009027 insemination Effects 0.000 description 2
- 239000012948 isocyanate Substances 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 210000004681 ovum Anatomy 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000011895 specific detection Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 229950010342 uridine triphosphate Drugs 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- QRXMUCSWCMTJGU-UHFFFAOYSA-L (5-bromo-4-chloro-1h-indol-3-yl) phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP([O-])(=O)[O-])=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-L 0.000 description 1
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- QRXMUCSWCMTJGU-UHFFFAOYSA-N 5-bromo-4-chloro-3-indolyl phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP(O)(=O)O)=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-N 0.000 description 1
- 241001147155 Acanthuridae Species 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- 108010000239 Aequorin Proteins 0.000 description 1
- 241000489963 Anabantoidei Species 0.000 description 1
- 241000480037 Argyrosomus japonicus Species 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 241001610600 Auxis rochei Species 0.000 description 1
- 241000722847 Auxis thazard Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241001418008 Callionymoidei Species 0.000 description 1
- 241000252229 Carassius auratus Species 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 241000489966 Channoidei Species 0.000 description 1
- 241000252233 Cyprinus carpio Species 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 241000252212 Danio rerio Species 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000269822 Euthynnus Species 0.000 description 1
- 241000549381 Gobiesocoidei Species 0.000 description 1
- 241000269882 Gobioidei Species 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101001037191 Homo sapiens Hyaluronan synthase 1 Proteins 0.000 description 1
- 101000741544 Homo sapiens Properdin Proteins 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 102100040203 Hyaluronan synthase 1 Human genes 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 241000045316 Labriformes Species 0.000 description 1
- 241001112471 Lambdavirus Species 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- 101710175625 Maltose/maltodextrin-binding periplasmic protein Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001596951 Nibea Species 0.000 description 1
- 241000961004 Nibea albiflora Species 0.000 description 1
- 241000704630 Nibea soldado Species 0.000 description 1
- 241000269859 Notothenioidei Species 0.000 description 1
- 241001638541 Odontesthes bonariensis Species 0.000 description 1
- 241000276569 Oryzias latipes Species 0.000 description 1
- 241000045603 Pelagiaria Species 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 108010004729 Phycoerythrin Proteins 0.000 description 1
- 241000242594 Platyhelminthes Species 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 238000010802 RNA extraction kit Methods 0.000 description 1
- 108010065868 RNA polymerase SP6 Proteins 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000277331 Salmonidae Species 0.000 description 1
- 241000277295 Salvelinus Species 0.000 description 1
- 241000269847 Sarda orientalis Species 0.000 description 1
- 241001417494 Sciaenidae Species 0.000 description 1
- 241000736081 Scomber Species 0.000 description 1
- 108091081021 Sense strand Proteins 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 241000161206 Sphaeramia nematoptera Species 0.000 description 1
- 101710137500 T7 RNA polymerase Proteins 0.000 description 1
- 239000006180 TBST buffer Substances 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 241000269849 Thunnus Species 0.000 description 1
- 241000269956 Thunnus maccoyii Species 0.000 description 1
- 241000269957 Thunnus obesus Species 0.000 description 1
- 241000276707 Tilapia Species 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 241000397921 Turbellaria Species 0.000 description 1
- PGAVKCOVUIYSFO-XVFCMESISA-N UTP Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 PGAVKCOVUIYSFO-XVFCMESISA-N 0.000 description 1
- 241000269780 Zoarcales Species 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 238000005571 anion exchange chromatography Methods 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000001109 blastomere Anatomy 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- WHLPIOPUASGRQN-UHFFFAOYSA-N butyl 2-methylprop-2-enoate;methyl 2-methylprop-2-enoate Chemical compound COC(=O)C(C)=C.CCCCOC(=O)C(C)=C WHLPIOPUASGRQN-UHFFFAOYSA-N 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 238000010805 cDNA synthesis kit Methods 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 238000005277 cation exchange chromatography Methods 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000009088 enzymatic function Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 125000005519 fluorenylmethyloxycarbonyl group Chemical group 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 108010021843 fluorescent protein 583 Proteins 0.000 description 1
- 108091006047 fluorescent proteins Proteins 0.000 description 1
- 102000034287 fluorescent proteins Human genes 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000004191 hydrophobic interaction chromatography Methods 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000002434 immunopotentiative effect Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 231100000707 mutagenic chemical Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 210000000287 oocyte Anatomy 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 210000003200 peritoneal cavity Anatomy 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 229940080469 phosphocellulose Drugs 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000003257 protein preparation method Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000003259 recombinant expression Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000009712 regulation of translation Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 239000003161 ribonuclease inhibitor Substances 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- PGAVKCOVUIYSFO-UHFFFAOYSA-N uridine-triphosphate Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)OC1N1C(=O)NC(=O)C=C1 PGAVKCOVUIYSFO-UHFFFAOYSA-N 0.000 description 1
- 108091005957 yellow fluorescent proteins Proteins 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/461—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Definitions
- the present invention relates to: a Vasa protein of Perciformes fish such as tuna; a Vasa gene of Perciformes fish such as tuna; a method for detecting the germ cell of Perciformes fish such as tuna, using such Vasa protein or Vasa gene as a target; a method for evaluating the growth and/or maturation of the germ cell of a Perciformes donor fish such as a tuna, which has been transplanted into a recipient fish of a different species, utilizing the aforementioned detection method; and the like.
- Vasa gene encodes ATP-dependent RNA helicase and that its functions are associated with regulation of translation from mRNA to a protein (for example, Liang, L., et al, Development, 120, 1201-1211, 1994).
- a structure for its enzymatic function is evolutionally strongly conserved.
- Vasa homolog genes have been identified in many multicellular animal species ranging from Platyhelminthes (planarian) to humans.
- a method for simply sorting a cell having germ cell differentiation potency using, as an indicator, the expression of a marker gene, without performing complicated operations such as homologous recombination there has been reported a method for obtaining a germ cell, which comprises recovering a cell having germ cell differentiation potency from a transgenic non-human mammal, into which a recombinant expression vector comprising a marker gene incorporated therein such that it is under the control of the promoter sequence of a Vasa homolog gene derived from the mammal has been introduced, using the expression of the marker gene as an indicator (for example, Japanese Laid-Open Patent Application Nos. 2006-333762 and 2003-235558).
- primordial germ cell is an original cell for egg and sperm, which is modified to an individual via processes of maturation and fertilization.
- a method for inducing the differentiation of a separated primordial germ cell derived from fish into a germ cell line which comprises transplanting the fish-derived separated primordial germ cell into the early embryo of a recipient fish of a different species, and particularly transplanting the separated primordial germ cell into the peritoneal cavity of a recipient fish of a different species at the early development stage (for example, Japanese Patent Laid-Open Nos. 2006-333762 and 2003-235558).
- tuna reaches initial maturation after its body weight has exceeded several tens of kilograms. Since the body size of tuna is large, differing from other fish species, it is grown by a seedling production by a method of collecting fertilized eggs naturally laid by parent fish in a preserve or in an enclosed bay using a finely-woven net. Since Pagrus major and the like lay eggs in a water tank, a device for collecting the eggs with a net by overflowing seawater on the surface of the tank can be easily produced. However, when such operation is carried out at sea, it is very troublesome.
- Surrogate fish technique is a technique of allowing fish species that are suitable for seedling production to produce the gametes of fish species that are unsuitable for seedling production, or to lay eggs and then to be subjected to insemination, so as to simply allow seedling production at low costs.
- the surrogate fish technique described in the aforementioned Patent Document 2 is applied to tuna, so as to allow small-sized fish species used as recipient fishes to maturate tuna-derived germ cells, full cultivation including seedling production can be achieved in a small water tank, and it is expected to result in significant laborsaving and cost reduction.
- the present inventors have succeeded in producing a rainbow trout from a masu salmon ( Oncorhynchus masou ) by carrying out heteroplastic germ cell transplantation on Salmonidae fish.
- a genetically modified fish line in which the germ cell of a rainbow trout had been visualized with a green fluorescent protein was used, and as a result, it became possible to easily confirm the success or failure of the transplantation.
- a method for confirming the success or failure of the transplantation without using a genetically modified fish line has already been developed.
- the present inventors have succeeded in detecting wild-type rainbow trout germ cells surviving at the genital gland of a Salvelinus pulvius host.
- the present inventors aim to apply this heteroplastic germ cell transplantation method to other marine fish species.
- it is essential to develop a method for confirming whether or not the transplanted germ cells of a Perciformes donor fish such as a tuna have been incorporated into the genital gland of a host and they survive therein.
- the present inventors have selected Vasa gene from among Nanos gene, Deadend gene, Vasa gene, and other genes, which had been known to be specifically expressed in primordial germ cells. Thereafter, the inventors have determined for the first time the nucleotide sequences of the Vasa genes of a tuna, a chub mackerel, a spotted mackerel, an eastern little tune, and a drum fish. Further, the inventors have focused on a tuna Vasa gene, which is most likely to become a Perciformes donor fish, and they have confirmed that such tuna Vasa gene is specifically expressed in the primordial germ cell and spermatogonium/oogonium of a tuna.
- the inventors have specified a region characteristic for the tuna Vasa gene, and thus they have found that this region can be used as an identification marker for a spermatogonium/an oogonium derived from tuna primordial germ cells.
- this region can be used as an identification marker for a spermatogonium/an oogonium derived from tuna primordial germ cells.
- it is essential to establish a method of distinguishing a tuna Vasa gene from a host Vasa gene and then detecting only the tuna gene.
- the inventors of the present application have carried out nested PCR that enables highly specific amplification from a trace amount of DNA, so that they could specifically detect a tuna Vasa gene. Furthermore, the inventors have compared the sequence of a tuna Vasa gene with the sequence of a Vasa gene of another Perciformes fish, and as a result, they have specified a restriction enzyme sequence existing only in the tuna Vasa gene. By combining such nested PCR with a restriction enzyme treatment, the present inventors have established a method for more reliably detecting a tuna Vasa gene, thereby completing the present invention.
- the present invention relates to
- the present invention relates to
- the present invention relates to
- the present invention relates to
- the present invention relates to
- FIG. 1 [ FIG. 1 ]
- FIG. 1 is a view showing the results obtained by staining the testis tissues of a bluefin tuna by in situ hybridization using an RNA probe specific to a bluefin tuna Vasa gene.
- FIG. 2 [ FIG. 2 ]
- FIG. 2 is a view showing the results obtained by staining the testis tissues of a bluefin tuna and those of a drumfish ( Nibea mitsukurii ) by in situ hybridization using an RNA probe specific to the Vasa gene of each fish.
- FIG. 3 [ FIG. 3 ]
- FIG. 3 is a view showing sites recognized by bluefin tuna Vasa cDNA detection primers and restriction enzyme.
- Bluefin tuna vasa cDNA corresponds to the nucleotide sequence spanning nucleotide positions 1381-1859 in SEQ ID NO: 1
- “Drumfish vasa cDNA” corresponds to the nucleotide sequence spanning nucleotide positions 589-1068 in SEQ ID NO: 18, respectively.
- FIG. 4-1 [ FIG. 4-1 ]
- FIG. 4-1 is a view showing the results obtained by performing PCR using, as a template, a sample obtained by adding a different amount of a cDNA derived from the ovary of a bluefin tuna to a cDNA derived from the ovary of a drumfish ( Nibea mitsukurii ).
- FIG. 4-2 [ FIG. 4-2 ]
- FIG. 4-2 is a view showing a bluefin tuna Vasa sequence (179 bp) amplified by PCR, which is cleaved by HpaI into fragments of 146 bp and 33 bp.
- FIG. 5 [ FIG. 5 ]
- FIG. 5 is a view showing the results obtained by analyzing a sample collected from the genital gland of a drumfish ( Nibea mitsukurii ).
- FIG. 6 is a view showing a comparison made among a bluefin tuna Vasa gene region amplified by the nested PCR of Example 5, and the Vasa gene regions of a drumfish ( Nibea mitsukurii ), a mackerel, and an eastern little tuna ( Euthynnus affinis ), which are highly homologous with the bluefin tuna Vasa gene region.
- “Bluefin” corresponds to the nucleotide sequence spanning nucleotide positions 1462-1819 in SEQ ID NO: 1
- “nibe” corresponds to the nucleotide sequence spanning nucleotide positions 1418-1775 in SEQ ID NO: 9
- “saba” corresponds to the nucleotide sequence shown in SEQ ID NO: 23
- “suma” corresponds to the nucleotide sequence shown in SEQ ID NO: 24, respectively.
- FIG. 7 is a view showing the results obtained by performing nested PCR using, as a template, a sample derived from the ovary of a mackerel and that of an eastern little tuna ( Euthynnus affinis ), and then treating the PCR product with HpaI.
- the protein of the present invention is not particularly limited, as long as it is a protein consisting of the amino acid sequence shown in SEQ ID NO: 2 of the sequence listing (tuna Vasa protein); a protein comprising a substitution, deletion, insertion, or addition or one or several amino acids with respect to the amino acid sequence shown in SEQ ID NO: 2 and being specifically expressed in a tuna germ cell; or a protein consisting of an amino acid sequence having homology of at least 85% with the amino acid sequence shown in SEQ ID NO: 2 of the sequence listing and being specifically expressed in a tuna germ cell.
- tuna is used in the present invention as a generic name for fishes of Perciformes, Scombroidei, Scombridae, and Thunnus.
- Specific examples of such tuna include bluefin tuna, bigeye tuna, southern bluefin tuna, yellowfin tuna, albacore tuna, northern bluefin tuna, and longtail tuna. Among these, bluefin tuna is preferred.
- protein being specifically expressed in a tuna germ cell is used in the present invention to mean a protein, which is expressed only in a primordial germ cell, a spermatogonium, and/or an oogonium that are the germ cells of tuna, and which is not expressed in a primordial germ cell, a spermatogonium, and/or an oogonium that are the germ cells of fish species other than tuna.
- the protein of the present invention is not particularly limited, as long as it is a protein consisting of the amino acid sequence shown in SEQ ID NO: 4 (chub mackerel Vasa protein), SEQ ID NO: 6 (spotted mackerel Vasa protein), SEQ ID NO: 8 (eastern little tuna ( Euthynnus affinis ) Vasa protein), or SEQ ID NO: 10 (drumfish ( Nibea mitsukurii ) Vasa protein) of the sequence listing; a protein consisting of an amino acid sequence comprising a substitution, deletion, insertion, or addition of one or several amino acids with respect to the amino acid sequence shown in SEQ ID NO: 4, 6, 8, or 10, and being specifically expressed in the germ cell of a Perciformes fish; or a protein consisting of an amino acid sequence having homology of at least 85% with the amino acid sequence shown in SEQ ID NO: 4, 6, 8, or 10 of the sequence listing, and being specifically expressed in the germ cell of a Perciformes fish.
- Perciformes includes Percoidei, Labroidei, Zoarcoidei, Notothenioidei, Trachinoidei, Blennoidei, Gobiesocoidei, Callionymoidei, Gobioidei, Acanthuridae, Scombroidei, Stromateoidei, Anabantoidei, Channoidei, and the like.
- the aforementioned chub mackerel and spotted mackerel are fishes belonging to Perciformes, Scombroidei, Scombridae, Scomber.
- the aforementioned eastern little tuna is a generic name for fishes belonging to Perciformes, Scombroidei, Scombridae, Euthynnus, and it includes eastern little tuna (scientific name: Euthynnus affinis ), frigate mackerel, bullet tuna, oriental bonito, and the like.
- eastern little tuna used as a collective noun in the present specification is distinguished from eastern little tuna ( Euthynnus affinis ) that indicates a specific fish species, based on the presence or absence of the scientific name.
- drumfish is a generic name for fishes belonging to Perciformes, Percoidei, Sciaenidae, Nibea, and it includes drumfish (scientific name: Nibea mitsukurii ), Nibea albiflora , soldier croaker, mulloway, pajama cardinalfish, drum, and the like.
- drumfish used as a collective noun in the present specification is distinguished from drumfish ( Nibea mitsukurii ) that indicates a specific fish species, based on the presence or absence of the scientific name.
- tuna, chub mackerel, spotted mackerel, and eastern little tuna are all classified into Scombroidei in Perciformes, and thus these fish species are particularly preferably used in heteroplastic transplantation.
- an amino acid sequence comprising a substitution, deletion, insertion, or addition of one or several amino acids means an amino acid sequence comprising a substitution, deletion, insertion, or addition of any given number of, for example 1 to 20, preferably 1 to 15, more preferably 1 to 10, and further preferably 1 to 5 amino acids.
- an amino acid sequence having homology of at least 85% with the amino acid sequence shown in SEQ ID NO: 2, 4, 6, 8, or 10 is not particularly limited, as long as it has homology of 85% or more with the amino acid sequence shown in SEQ ID NO: 2, 4, 6, 8, or 10.
- homology is, for example, 85% or more, preferably 90% or more, more preferably 95% or more, and particularly preferably 98% or more.
- a method of obtaining or preparing the protein of the present invention is not particularly limited. Any one of an isolated, naturally-derived protein, a chemically synthesized protein, and a recombinant protein produced by a genetic recombination technique may be used. In the case of obtaining a naturally-derived protein, the protein of the present invention can be obtained from cells that express such protein by appropriately combining methods of isolating and purifying protein.
- the protein of the present invention can also be synthesized based on the amino acid sequence information, using various types of commercially available peptide synthesizers.
- a DNA encoding the protein is introduced into a preferred expression system, so as to prepare the protein of the present invention.
- a genetic recombination technique that is capable of prepare a large amount of protein by comparatively easily operations is preferred.
- the protein of the present invention is prepared by such genetic recombination technique
- precipitation with ammonium sulfate or ethanol and acid extraction are carried out, and thereafter, known methods including anion or cation exchange chromatography, phosphocellulose chromatography, hydrophobic interaction chromatography, affinity chromatography, hydroxyapatite chromatography, and lectin chromatography are used.
- high performance liquid chromatography is used.
- a column used in affinity chromatography for example, a column to which an antibody such as a monoclonal antibody against the protein of the present invention is allowed to bind, or in a case in which an ordinary peptide tag is added to the aforementioned protein of the present invention, a column to which a substance having affinity for the peptide tag is allowed to bind, is used to obtain a purified product of such protein.
- the protein of the present invention prepared by the aforementioned methods can be used in a method for specifically detecting a primordial germ cell, a spermatogonium, and/or an oogonium derived from Perciformes.
- a person skilled in the art could appropriately prepare or obtain a protein consisting of an amino acid sequence comprising a substitution, deletion, insertion, or addition of one or several amino acids with respect to the amino acid sequence shown in SEQ ID NO: 2, 4, 6, 8, or 10, or a protein consisting of an amino acid sequence having homology of at least 85% with the amino acid sequence shown in SEQ ID NO: 2, 4, 6, 8, or 10 of the sequence listing, based on information regarding the nucleotide sequence shown in SEQ ID NO: 1, 3, 5, 7, or 9 of the sequence listing, which is given as an example of a nucleotide sequence encoding, respectively, the amino acid sequence shown in SEQ ID NO: 2, 4, 6, 8, or 10.
- PCR reaction polymerase chain reaction
- primers oligonucleotides synthesized based on the nucleotide sequence shown in SEQ ID NO: 1, 3, 5, 7, or 9, or by hybridization using, as a probe, an oligonucleotide synthesized based on the same above nucleotide sequence
- DNA homologs from tuna species other than bluefin tuna are screened under appropriate conditions, so as to isolate them.
- the entire-length DNA of this homolog DNA is cloned, incorporated into an expression vector, and then allowed to express in a suitable host, so that a protein encoded by the homolog DNA can be produced.
- An oligonucleotide can be synthesized according to an ordinary method, for example, using various commonly available DNA synthesizers.
- a PCR reaction can be carried out according to an ordinary method employing the Gene Amp PCR system 2400 Thermal Cycler manufactured by Applied Biosystems, and using Taq DNA polymerase (manufactured by Takara Bio Inc.) or KOD-Plus-(manufactured by Toyobo Co., Ltd.).
- the aforementioned protein of the present invention may be allowed to bind to a marker protein and/or a peptide tag to produce a fusion protein.
- the type of a marker protein is not particularly limited, as long as it is a conventionally known marker protein.
- Specific examples of such marker protein include luciferase, alkaline phosphatase, enzyme such as HRP, an antibody Fc region, and fluorescent substances such as GFP, YFP, CFP, DsRed and aequorin.
- Such peptide tag include conventionally known peptide tags including epitope tags such as HA, FLAG and Myc, affinity tags such as GST, a maltose binding protein, a biotinylated peptide and oligohistidine.
- Such fusion protein can be produced by an ordinary method, and it is useful for purification of the protein of the present invention using the affinity of Ni-NTA with a His tag, detection of the protein of the present invention, or quantification of an antibody against the protein of the present invention, and is also useful as a reagent for studies in the present field.
- the DNA of the present invention is not particularly limited, as long as it is a DNA encoding a protein consisting of the amino acid sequence shown in SEQ ID NO: 2; a DNA encoding a protein, which consists of an amino acid sequence comprising a substitution, deletion, insertion, or addition of one or several amino acids with respect to the amino acid sequence shown in SEQ ID NO: 2, and which is specifically expressed in a tuna germ cell; a DNA encoding a protein, which consists of an amino acid sequence having homology of at least 85% with the amino acid sequence shown in SEQ ID NO: 2, and which is specifically expressed in a tuna germ cell; a DNA consisting of the nucleotide sequence shown in SEQ ID NO: 1 (a bluefin tuna Vasa gene); a DNA, which hybridizes under stringent conditions with a DNA consisting of a sequence complementary to the nucleotide sequence shown in SEQ ID NO: 1, and which encodes a protein specifically expressed in a tuna germ cell; a DNA, which hybridize
- nucleotide sequence comprising a substitution, deletion, insertion, or addition of one or several nucleotides means a nucleotide sequence comprising a substitution, deletion, insertion, or addition of any given number of, for example 1 to 20, preferably 1 to 15, more preferably 1 to 10, and further preferably 1 to 5 nucleotides.
- the DNA of the present invention encoding a protein that is specifically expressed in a tuna germ cell may encode a protein comprising a deletion, substitution, insertion, or addition of one or several amino acids at one or several positions, unless it impairs the function of a tuna Vasa protein.
- Such DNA encoding a protein that is specifically expressed in a tuna germ cell can also be obtained by subjecting nucleotide(s) at specific site(s) to a deletion, substitution, insertion, or addition of nucleotide(s), so as to modify the nucleotide sequence, for example, by site-directed mutagenesis.
- the above modified DNA can also be obtained by conventionally known mutagenesis.
- the DNA of the present invention is not particularly limited, as long as it is a DNA encoding a protein consisting of the amino acid sequence shown in SEQ ID NO: 4, 6, 8, or 10; a DNA encoding a protein, which consists of an amino acid sequence comprising a substitution, deletion, insertion, or addition of one or several amino acids with respect to the amino acid sequence shown in SEQ ID NO: 4, 6, 8, or 10, and which is specifically expressed in the germ cell of a Perciformes fish; a DNA encoding a protein, which consists of an amino acid sequence having homology of at least 85% with the amino acid sequence shown in SEQ ID NO: 4, 6, 8, or 10, and which is specifically expressed in the germ cell of a Perciformes fish; a DNA consisting of the nucleotide sequence shown in SEQ ID NO: 3 (chub mackerel Vasa gene), NO: 5 (spotted mackerel Vasa gene), NO: 7 (eastern little tuna ( Euthynnus affinis ) Vasa
- nucleotide sequence comprising a substitution, deletion, insertion, or addition of one or several nucleotides means a nucleotide sequence comprising a substitution, deletion, insertion, or addition of any given number of, for example 1 to 20, preferably 1 to 15, more preferably 1 to 10, and further preferably 1 to 5 nucleotides.
- the DNA of the present invention encoding a protein specifically expressed in the germ cell of a Perciformes fish may encode a protein comprising a deletion, substitution, insertion, or addition of one or several amino acids at one or several positions, unless it impairs the function of a Vasa protein.
- Such DNA encoding a protein that is specifically expressed in the germ cell of a Perciformes fish can also be obtained by subjecting nucleotide(s) at specific site(s) to a deletion, substitution, insertion, or addition of nucleotide(s), so as to modify the nucleotide sequence, for example, by site-directed mutagenesis.
- the above modified DNA can also be obtained by conventionally known mutagenesis.
- a DNA consisting of a nucleotide sequence comprising a substitution, deletion, insertion, or addition of one or several nucleotides can also be produced by any given methods known to persons skilled in the art, such as chemical synthesis, a genetic engineering method, or mutagenesis.
- a mutation is introduced into a DNA consisting of the nucleotide sequence shown in SEQ ID NO: 1 by a method of allowing an agent acting as a mutagen to come into contact with and act on the DNA, a method of applying ultraviolet ray to the DNA, a genetically engineering method, or the like, thereby obtaining a mutant DNA.
- Site-directed mutagenesis used as a genetically engineering method is a useful method capable of introducing a specific mutation into a specific site, and this method is carried out according to the methods described in Molecular Cloning: A laboratory Manual, 2nd Ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y., 1989; Current Protocols in Molecular Biology, Supplement 1-38, John Wiley & Sons (1987-1997); etc.
- a protein consisting of an amino acid sequence comprising a substitution, deletion, insertion, or addition of one or several amino acids can be obtained.
- under stringent conditions is used to mean conditions under which a so-called specific hybrid is formed and a non-specific hybrid is not formed.
- Specific examples of such stringent conditions include: conditions under which DNA portions having homology of 50% or more, and preferably 70% or more hybridize with each other and DNA portions having homology lower than that as described above do not hybridize with each other; and washing conditions in ordinary Southern hybridization, under which hybridization is carried out at 65° C. in a salt concentration corresponding to a 1 ⁇ SSC solution (wherein the composition of a 1-fold concentration of SSC solution consists of 150 mM sodium chloride and 15 mM sodium citrate) and 0.1% SDS, or 0.1 ⁇ SSC and 0.1 SDS.
- DNA which hybridizes under stringent conditions
- a DNA obtained by applying a colony hybridization method, a plaque hybridization method, a Southern blot hybridization, or the like using a nucleic acid such as DNA or RNA as a probe.
- a specific example of such DNA is a DNA, which can be identified by carrying out hybridization at 65° C. in the presence of 0.7 to 1.0 M NaCl using a filter, on which a colony- or plaque-derived DNA or a fragment thereof has been immobilized, and then by washing the filter at 65° C. using an approximately 0.1 to 2 ⁇ SSC solution.
- Hybridization can be carried out according to the method described in Molecular Cloning, 2nd Ed.
- An example of a DNA capable of hybridizing with another DNA under stringent conditions is a DNA having a certain level of homology with the nucleotide sequence of a DNA used as a probe.
- a preferred example of such DNA is a DNA having homology of, for example, 60% or more, preferably 70% or more, more preferably 80% or more, further preferably 90% or more, particularly preferably 95% or more, and most preferably 98% or more, with another DNA.
- a method of obtaining or preparing a DNA of the present invention is not particularly limited.
- An appropriate probe or primer is prepared based on the information of the nucleotide sequence shown in SEQ ID NO: 1 or the information of the amino acid sequence shown in SEQ ID NO: 2 disclosed in the present specification. Thereafter, using such probe or primer, a cDNA library in which the DNA is estimated to exist is screened to isolate the DNA of interest. Alternatively, such DNA can also be prepared by carrying out chemical synthesis according to an ordinary method.
- a cDNA library is prepared from tuna according to an ordinary method, and thereafter, a desired clone is selected from this library using an appropriate probe specific to the genetic DNA of the present invention, so as to obtain the genetic DNA of the present invention.
- separation of total RNA from tuna, separation and purification of mRNA, the obtainment of cDNA, and the cloning thereof can all be carried out according to ordinary methods.
- Examples of a method of screening the genetic DNA of the present invention from a cDNA library include methods commonly used by persons skilled in the art, such as the method described in Molecular Cloning, 2nd Ed.
- the recombinant vector of the present invention is not particularly limited, as long as it comprises the aforementioned gene of the present invention and is able to express a protein specific to the germ cell of a Perciformes fish.
- the recombinant vector of the present invention can be constructed by appropriately integrating the DNA of the present invention into an expression vector used for animal cells or an expression vector used for microorganisms.
- an expression vector capable of autonomously replicating in a host cell or an expression vector capable of being incorporated into the chromosome of a host cell is preferred.
- an expression vector comprising control sequences such as a promoter, an enhancer, and a terminator at positions that enable the expression of the DNA of the present invention, can preferably be used.
- the DNA of the present invention produced by the aforementioned method can be used for a method for specifically detecting a primordial germ cell, a spermatogonium, and/or an oogonium derived from Perciformes.
- the recombinant vector of the present invention can also be used to produce a transformant.
- transformation commonly used transformation methods can all be applied.
- a vector is packaged in a retrovirus particle or a lambda virus particle, and it is then transferred into a cell.
- microinjection electroporation, calcium phosphate precipitation, or a biolistic method (for example, tungsten bombardment), or by allowing a naked nucleic acid vector or construct to come into contact with a cell in a solution, such vector can be introduced into a cell.
- introduction by microinjection is particularly preferred.
- Such microinjection can be carried out before or after fertilization, or at the two-celled, four-celled or eight-celled stage after cleavage.
- the obtained cells are cultured by an ordinary method, so that they are allowed to grow to an embryo, a baby fish, a juvenile fish, a young fish, and a mature fish, which have germ cells.
- an antibody of the present invention examples include a monoclonal antibody, a polyclonal antibody, a single-stranded antibody, a humanized antibody, a chimeric antibody, and a bifunctional antibody capable of simultaneously recognizing two epitopes. These antibodies are produced by administering a fragment containing the protein of the present invention or an epitope, an analog, or the like to animals (preferably, animals other than a human) in accordance with commonly used protocols.
- a monoclonal antibody there can be used any given methods such as a hybridoma method (Nature 256, 495-497, 1975), a trioma method, a human B cell hybridoma method (Immunology Today 4, 72, 1983), and an EBV-hybridoma method (MONOCLONAL ANTIBODIES AND CANCER THERAPY, pp. 77-96, Alan R. Liss, Inc., 1985), which bring on antibodies produced from a culture product of a continuous cell line.
- an Fab fragment or an F(ab′)2 fragment of the aforementioned antibodies, and the like may also be used similarly as the aforementioned antibodies.
- a peptide consisting of 4 or more, preferably 6 or more, and more preferably 10 or more amino acids, encoded by the Vasa gene of the present invention may be synthesized and used. Or, there may be used a product obtained by allowing a part of or the entire Vasa gene of the present invention to express in the cell of phage, Escherichia coli , Actinomycetes, lactic acid bacteria, yeast, a cultured cell, or the like. Otherwise, the entire or a part of a Vasa gene product may be purified from a fish individual or cell thereof, and it may be then used.
- the antigen in order to produce an antibody specifically recognizing the Vasa gene product of a Perciformes fish as a target, it is preferred to select a gene region encoding an amino acid sequence specific to the Perciformes fish species as a target from the amino acid sequence of a Vasa protein.
- the antigen may be directly used. Otherwise, the antigen may be mixed with or bind to an immunopotentiating agent or adjuvant such as hapten, and it may be then used.
- Labeled antibodies produced by labeling the aforementioned antibodies for example, with fluorescent substances such as FITC (fluorescein isocyanate) or tetramethylrhodamine isocyanate, with radioisotopes such as 125I, 32P, 14C, 35S or 3H, or with enzymes such as alkaline phosphatase, peroxidase, ⁇ -galactosidase or phycoerythrin, or fusion proteins produced by fusing such antibodies with fluorescent proteins such as green fluorescent protein (GFP), can be used to detect and measure the protein of the present invention by an immunological method.
- fluorescent substances such as FITC (fluorescein isocyanate) or tetramethylrhodamine isocyanate
- radioisotopes such as 125I, 32P, 14C, 35S or 3H
- enzymes such as alkaline phosphatase, peroxidase, ⁇ -galactosidase or phycoerythr
- the present invention relates to a primer set for detecting the presence of a DNA and/or mRNA encoding the Vasa protein of the present invention that is specifically expressed in a germ cell.
- a primer set for detecting the presence of a DNA or mRNA encoding a protein specifically expressed in a tuna germ cell the length of the primer sequence, the site of the nucleotide sequence of a nucleic acid to which the primer set is complementary, and the like are not particularly limited, as long as it is a complementary primer set capable of hybridizing with a portion of a sequence upstream or downstream of the DNA, mRNA, or cDNA of the protein.
- primers comprise a sequence wherein a part is not complementary to the DNA, mRNA, or cDNA sequence of the aforementioned peptide on the 5′- or 3′-terminal side or on both sides, as far as they are able to hybridize with them, they can be used as primers.
- primers in order to prevent non-specific amplification or to introduce a suitable restriction enzyme recognition site, it is possible to use a primer having a mismatch sequence that is not complementary to such DNA, mRNA, or cDNA.
- the present invention relates to a probe for detecting the presence of a DNA and/or mRNA encoding the protein of the present invention that is specifically expressed in a germ cell.
- a preferred example of a probe for detecting the presence of a DNA or mRNA encoding a protein specifically expressed in a tuna germ cell is a probe, which is the entire or a part of antisense strand capable of hybridizing with a DNA (cDNA) or RNA (cRNA) encoding such peptide, and which has a length necessary as a probe (at least 20 bases or more).
- probe even if such probe comprises a sequence wherein a part is not complementary to the DNA, mRNA, or cDNA sequence of the aforementioned peptide on the 5′- or 3′-terminal side or on both sides, as far as the probe is able to hybridize with them, it can be used as a probe.
- a probe to which any given sequence has been added can be used.
- a probe whose 5′-terminus has been labeled can also be used. Examples of a labeling substance used herein include biotin, fluorescence, and P32.
- the method of the present invention for identifying a primordial germ cell, a spermatogonium, or an oogonium derived from a donor fish is not particularly limited, as long as it is a method by which the presence of a DNA and/or mRNA encoding a protein specifically expressed in a tuna germ cell in a sample is detected by an in situ hybridization method or the like using the aforementioned primer set or labeled probe of the present invention, and when the presence of such DNA and/or mRNA is detected in the sample, it is evaluated that a primordial germ cell, a spermatogonium, or an oogonium derived from a tuna is present in the sample.
- restriction enzyme used in the aforementioned method is not particularly limited, as long as it is used to obtain DNA fragments with different lengths between a DNA derived from a donor fish and a DNA derived from a recipient fish of a different species, such as restriction enzyme whose recognition sequence exists in a donor fish Vasa gene region to be amplified but does not exist in a different species of recipient fish Vasa gene region, restriction enzyme whose recognition sequence does not exist in a donor fish Vasa gene region to be amplified but exists in a different species of recipient fish Vasa gene region, and restriction enzyme whose recognition sequence exists both in a donor fish Vasa gene region to be amplified and in a different species of recipient fish Vasa gene region, but which number of such recognition sequences is different.
- HapI can be exemplified.
- An example of an identification method using the aforementioned HapI is a method, which comprises performing nested PCR using a first primer set consisting of the nucleotide sequences shown in SEQ ID NOS: 19 and 20 and a nested primer set consisting of the nucleotide sequences shown in SEQ ID NOS; 21 and 22, then treating the obtained PCR product with the restriction enzyme HapI, and then determining that the above PCR product is a tuna Vasa gene, when the PCR product is digested to DNA fragments of 146 bp and 33 bp.
- the identification method of the present invention is useful as a method for evaluating the growth and/or maturation of a germ cell derived from a donor fish transplanted into a recipient fish of a different species.
- a primordial germ cell separated from a tuna is transplanted into the early embryo of a recipient fish of a different species such as a drumfish, a mackerel, an eastern little tuna or a Pagrus major , which seeding production can be conducted more simply with higher efficiency than a tuna, and preferably, such primordial germ cell is transplanted into the abdominal cavity of a recipient fish of a different species at the early developing stage, so that the aforementioned primordial germ cell can be induced to differentiate into a germ cell line.
- a tuna-derived primordial germ cell is induced to differentiate into an oocyte or a spermatogonium, and is further induced to differentiate into an ovary or a sperm, thereby enabling the growth and breeding of tuna.
- the testis was excised from each of five cultivated male bluefin tuna fishes (3-year-old; body weight: approximately 50 kg), which was then frozen rapidly on dry ice. Total RNA was extracted from the obtained testis tissues using ISOGEN (manufactured by Nippon Gene Co., Ltd.).
- a 40 mM Tris-HCl (pH 7.8) solution containing 2.2 U/ml RQ1 RNasa-Free DNase (manufactured by Promega), RNase inhibitor (manufactured by Toyobo Co., Ltd.), 10 mM NaCl, 6 mM MgCl2, and 10 mM Dithiothreitol (DTT) was added, and the obtained mixture was then incubated at 37° C. for 60 minutes. Thereafter, phenol/chloroform extraction and ethanol precipitation were performed on the reaction solution, so as to purify total RNA, and the concentration and purity thereof were then measured.
- a 5′-RACE primer as shown in SEQ ID NO: 13 and a 3′-RACE primer as shown in SEQ ID NO: 14 were designed.
- a RACE-PCR reaction was carried out employing GeneRacerTM KIT (Invitrogen), so as to amplify the 5′-terminal side sequence and 3′-terminal side sequence of the bluefin tuna Vasa gene.
- the nucleotide sequences of the 5′- and 3′-terminal sides were determined, and they were then ligated to the aforementioned nucleotide sequence to obtain the nucleotide sequence of an entire-length bluefin tuna Vasa gene.
- the cDNA of bluefin tuna Vasa used as a template had a hairpin structure, and thus it was impossible to amplify the sequence up to its 5′-terminus only with a 5′-RACE primer A.
- a 5′-RACE primer B as shown in SEQ ID NO: 15 was newly designed from a nucleotide sequence determined by a RACE-PCR reaction using the 5′-RACE primer A, and a RACE-PCR reaction was carried out again to amplify a DNA fragment at the 5′-terminus, so as to determine an entire-length bluefin tuna Vasa nucleotide sequence as shown in SEQ ID NO: 1 and a bluefin tuna Vasa amino acid sequence as shown in SEQ ID NO: 2.
- the Vasa gene of chub mackerel (SEQ ID NO: 3), the Vasa gene of spotted mackerel (SEQ ID NO: 5), the Vasa gene of eastern little tuna ( Euthynnus affinis ) (SEQ ID NO: 7), and the Vasa gene of drumfish ( Nibea mitsukurii ) (SEQ ID NO: 9) were each determined. Thereafter, amino acid sequences (SEQ ID NOS: 4, 6, 8, and 10) corresponding to these gene sequences were determined.
- a PCR reaction was carried out with the primer shown in SEQ ID NO: 15 and the primer shown in SEQ ID NO: 16, so as to amplify a bluefin tuna Vasa fragment of 1090 by as shown in SEQ ID NO: 17.
- the obtained DNA fragment was inserted into a pGEM-T easy vector (manufactured by Promega), and it was then subcloned.
- an in vitro transcription reaction was carried out using digoxigenin (DIG)-labeled uridine triphosphate (DIG-11-UTP; manufactured by Roche) and RNA polymerase (SP6 or T7 RNA polymerase; manufactured by Promega), so as to synthesize sense-strand and antisense-strand RNA probes.
- DIG digoxigenin
- DIG-11-UTP digoxigenin-labeled uridine triphosphate
- SP6 or T7 RNA polymerase manufactured by Promega
- a 5- ⁇ m section was prepared from bluefin tuna testis tissues fixed with a Bouin's fluid, and it was then developed on a slide glass to produce a tissue section sample.
- a hybridization reaction solution (a 5 ⁇ SSC solution (pH 4.5) containing 50 ⁇ g/ml tRNA, 50% formaldehyde, 50 ⁇ g/ml heparin, and 1% SDS) containing 1 ⁇ g/ml RNA probe produced in Example 3 was placed on the section, and it was then reacted at 65° C. for 18 hours. Thereafter, the reaction product was washed with a 1 ⁇ SSC solution containing 50% formamide, and then substituted with a 1 ⁇ TBST solution. Thereafter, the reaction solution was incubated with a blocking solution for hybridization (manufactured by Roche) for 1 hour.
- a blocking solution for hybridization manufactured by Roche
- signal amplification was carried out using TSATM PlusDNP AP System (PerkinElmer Japan).
- Such signal amplification comprises a step of incubating the section sample obtained after blocking with horseradish peroxidase-labeled anti-DIG, Fab fragments (Anti-DIG-POD, Fab fragments: manufactured by Roche) for 30 minutes; and a step of adding dinitrophenyl (DNP)-labeled tyramide dropwise to the slide glass. Thereafter, the resultant was incubated with an alkaline phosphatase (AP)-labeled-anti-DNP antibody for 30 minutes.
- AP alkaline phosphatase
- RNA probe specifically hybridizing with a drumfish ( Nibea mitsukurii ) Vasa gene and a drumfish ( Nibea mitsukurii ) testis tissue section were produced, and they were then used as negative controls.
- Such RNA probe was produced by inserting the gene sequence specific to drumfish ( Nibea mitsukurii ) shown in SEQ ID NO: 18 into a pGEM-T easy vector (manufactured by Promega) and then performing an in vitro transcription reaction by the same method as that of Example 3 using the gene sequence as a template.
- a drumfish ( Nibea mitsukurii ) testis tissue section sample was produced according to the method of Example 4, and in situ hybridization was then carried out.
- RNA probe produced in the present experiment specifically hybridizes with bluefin tuna Vasa.
- FIG. 3 shows the Vasa gene regions of drumfish ( Nibea mitsukurii ) having high homology with the bluefin tuna Vasa gene sequence, and the positions of primers and restriction enzyme HpaI recognition sites, which were used in the experiment.
- a 2 mm-square ovary section was collected from the immature ovary of a bluefin tuna or a drumfish ( Nibea mitsukurii ), and the collected section was then cut into fragments with dissecting scissors. Thereafter, the cells were dispersed by treatment with trypsin. With regard to the obtained two types of cell suspensions, cell density was measured using a blood cell counter. Thereafter, each suspension was adjusted to have a cell number of interest, and the two suspensions were then mixed.
- tRNA was extracted from cells in the prepared mixed solution using QuickPrep Total RNA Extraction Kit (manufactured by GE Healthcare), and cDNA was then synthesized using SuperScriptIII RNaseH Reverse Transcriptase (manufactured by Invitrogen). Nested PCR was carried out using a first primer set consisting of the nucleotide sequences shown in SEQ ID NOS: 19 and 20 and a nested primer set consisting of the nucleotide sequences shown in SEQ ID NOS: 21 and 22. A PCR reaction solution was prepared using TakaraExtaq (manufactured by Takara) in accordance with the protocols attached to the reagent. PCR reaction conditions consisted of: heat denaturation at 94° C.
- the PCR product was digested with restriction enzyme. Since the Vasa gene sequence of bluefin tuna is extremely highly homologous with that of drumfish ( Nibea mitsukurii ), it is highly likely that the two types of genes are both amplified by nested PCR. However, as shown in FIG. 3 , an HpaI recognition sequence existing in the sequence of the bluefin tuna does not exist in the drumfish ( Nibea mitsukurii ).
- mackerel and eastern little tuna which may be considered to be used as surrogate fish for bluefin tuna
- the Vasa gene sequences of bluefin tuna, drumfish ( Nibea mitsukurii ), mackerel, and eastern little tuna ( Euthynnus affinis ) show high homology with one another.
- a sequence having an HpaI recognition sequence is only that of bluefin tuna.
- Nested PCR was carried out in the same manner as Example 5. As a result, strong signals were obtained from both mackerel and eastern little tuna ( Euthynnus affinis ). The PCR products were treated with HpaI.
- Vasa gene which is a germ cell-specific gene, is specific to a primordial germ cell and a spermatogonium/an oogonium, and it is not expressed in a somatic cell.
- the Vasa gene sequences of a tuna, a chub mackerel, a spotted mackerel, an eastern little tuna, and a drumfish are determined, and the expression of such gene is used as a marker for a germ cell.
- a tuna-derived germ cell can be reliably and simply identified in the gonad of the recipient fish. As a result, the growth or breeding of tuna can be carried out with good efficiency.
- a germ cell derived from the donor fish can be efficiently detected from the gonad of a recipient fish of a different species.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Plant Pathology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
- (1) a protein consisting of the amino acid sequence shown in
SEQ ID NO 2 of the sequence listing; a protein, which consists of an amino acid sequence comprising a substitution, deletion, insertion, or addition of one or several amino acids with respect to the amino acid sequence shown in SEQ ID NO: 2 of the sequence listing, and which is specifically expressed in a tuna germ cell; or a protein, which consists of an amino acid sequence having homology of at least 85% or more with the amino acid sequence shown in SEQ ID NO: 2 of the sequence listing, and which is specifically expressed in a tuna germ cell, - (2) a DNA encoding a protein consisting of the amino acid sequence shown in SEQ ID NO: 2 of the sequence listing; a protein, which consists of an amino acid sequence comprising a substitution, deletion, insertion, or addition of one or several amino acids with respect to the amino acid sequence shown in SEQ ID NO: 2 of the sequence listing, and which is specifically expressed in a tuna germ cell; or a protein, which consists of an amino acid sequence having homology of at least 85% or more with the amino acid sequence shown in SEQ ID NO: 2 of the sequence listing, and which is specifically expressed in a tuna germ cell, and
- (3) a DNA consisting of the nucleotide sequence shown in SEQ ID NO: 1 of the sequence listing; a DNA, which hybridizes under stringent conditions with a DNA consisting of a sequence complementary to the nucleotide sequence shown in SEQ ID NO: 1 of the sequence listing, and which encodes a protein specifically expressed in a tuna germ cell; a DNA, which hybridizes under stringent conditions with a DNA consisting of a nucleotide sequence having a function as a primer or a probe produced from a portion of the nucleotide sequence shown in SEQ ID NO: 1 of the sequence listing, and which encodes a protein specifically expressed in a tuna germ cell; or a DNA, which consists of a nucleotide sequence comprising a substitution, deletion, insertion, or addition of one or several nucleotides with respect to the nucleotide sequence shown in SEQ ID NO: 1 of the sequence listing, and which encodes a protein specifically expressed in a tuna germ cell.
- (4) a protein consisting of the amino acid sequence shown in SEQ ID NO: 4, 6, 8, or 10 of the sequence listing; a protein, which consists of an amino acid sequence comprising a substitution, deletion, insertion, or addition of one or several amino acids with respect to the amino acid sequence shown in SEQ ID NO: 4, 6, 8, or 10 of the sequence listing, and which is specifically expressed in the germ cell of a Perciformes fish; or a protein, which consists of an amino acid sequence having homology of at least 85% or more with the amino acid sequence shown in SEQ ID NO: 4, 6, 8, or 10 of the sequence listing, and which is specifically expressed in the germ cell of a Perciformes fish,
- (5) a DNA encoding a protein consisting of the amino acid sequence shown in SEQ ID NO: 4, 6, 8, or 10 of the sequence listing; a protein, which consists of an amino acid sequence comprising a substitution, deletion, insertion, or addition of one or several amino acids with respect to the amino acid sequence shown in SEQ ID NO: 4, 6, 8, or 10 of the sequence listing, and which is specifically expressed in the germ cell of a Perciformes fish; or a protein, which consists of an amino acid sequence having homology of at least 85% or more with the amino acid sequence shown in SEQ ID NO: 4, 6, 8, or 10 of the sequence listing, and which is specifically expressed in the germ cell of a Perciformes fish, and
- (6) a DNA consisting of the nucleotide sequence shown in SEQ ID NO: 3, 5, 7, or 9 of the sequence listing; a DNA, which hybridizes under stringent conditions with a DNA consisting of a sequence complementary to the nucleotide sequence shown in SEQ ID NO: 3, 5, 7, or 9 of the sequence listing, and which encodes a protein specifically expressed in the germ cell of a Perciformes fish; a DNA, which hybridizes under stringent conditions with a DNA consisting of a nucleotide sequence having a function as a primer or a probe-produced from a portion of the nucleotide sequence shown in SEQ ID NO: 3, 5, 7, or 9 of the sequence listing, and which encodes a protein specifically expressed in the germ cell of a Perciformes fish; or a DNA, which consists of a nucleotide sequence comprising a substitution, deletion, insertion, or addition of one or several nucleotides with respect to the nucleotide sequence shown in SEQ ID NO: 3, 5, 7, or 9 of the sequence listing, and which encodes a protein specifically expressed in the germ cell of a Perciformes fish.
- (7) a recombinant vector comprising the DNA according to (2), (3), (5), or (6),
- (8) a transformant transformed with the recombinant vector according to (7),
- (9) a fusion protein or fusion peptide, or salt thereof obtained by binding the protein according to (1) or (4) with a marker protein and/or a peptide tag,
- (10) an antibody against the protein according to (1) or (4), or the fusion protein or fusion peptide according to (9), or salt thereof, and
- (11) a primer set or a probe for detecting the presence of a DNA and/or mRNA encoding the protein according to (1) or (4).
- (12) a method for detecting a primordial germ cell, a spermatogonium, or an oogonium derived from a Perciformes donor fish, which has been transplanted into a recipient fish of a different species, which methods comprises using the primer set or probe according to (11),
- (13) the detection method according to (12), which comprises: treating a DNA fragment amplified by PCR using the primer set according to (11) with at least one restriction enzyme; and determining whether or not the amplified DNA fragment is derived from the Perciformes donor fish, using the length of the digested or undigested DNA fragment as an indicator,
- (14) the detection method according to (12) or (13), wherein the Perciformes donor fish is a tuna,
- (15) the detection method according to (14), wherein the primer set is designed to amplify a region comprising a restriction enzyme HpaI recognition sequence existing in a DNA encoding the protein according to (1); and which method comprises treating a DNA fragment amplified by PCR using the primer set with HpaI, and determining that the DNA fragment is derived from bluefin tuna DNA, when it is digested, and
- (16) the detection method according to (15), wherein the PCR is nested PCR using a first primer set consisting of the nucleotide sequences shown in SEQ ID NOS: 19 and 20 and a nested primer set consisting of the nucleotide sequences shown in SEQ ID NOS: 21 and 22.
- (17) a method for detecting a primordial germ cell, a spermatogonium, or an oogonium derived from a Perciformes donor fish, which has been transplanted into a recipient fish of a different species, which method comprises using the antibody according to (10),
- (18) the detection method according to (17), wherein the Perciformes donor fish is a tuna,
- (19) a method for evaluating the growth and/or maturation of a tuna germ cell derived from a Perciformes donor fish transplanted into a recipient fish of a different species, which comprises the detection method according to any one of (12) to (18), and
- (20) the evaluation method according to (19), wherein the Perciformes donor fish is a tuna.
Claims (4)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007080022 | 2007-03-26 | ||
JP2007-080022 | 2007-03-26 | ||
PCT/JP2008/000743 WO2008129838A1 (en) | 2007-03-26 | 2008-03-26 | Germ cell marker using fish vasa gene |
Publications (2)
Publication Number | Publication Date |
---|---|
US20100132056A1 US20100132056A1 (en) | 2010-05-27 |
US8222385B2 true US8222385B2 (en) | 2012-07-17 |
Family
ID=39875370
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/532,304 Active 2028-07-26 US8222385B2 (en) | 2007-03-26 | 2008-03-26 | Germ cell marker using fish vasa gene |
Country Status (9)
Country | Link |
---|---|
US (1) | US8222385B2 (en) |
EP (1) | EP2133423B1 (en) |
JP (1) | JP5509417B2 (en) |
KR (1) | KR20100014457A (en) |
AU (1) | AU2008241974B2 (en) |
ES (1) | ES2401724T3 (en) |
IL (1) | IL201182A0 (en) |
MX (1) | MX2009010331A (en) |
WO (1) | WO2008129838A1 (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110244485A1 (en) * | 2008-09-25 | 2011-10-06 | National University Corporation Tokyo University Of Marine Science And Technology | Anti-tuna vasa antibody |
US10206709B2 (en) | 2012-05-14 | 2019-02-19 | Ethicon Llc | Apparatus for introducing an object into a patient |
US10258406B2 (en) | 2011-02-28 | 2019-04-16 | Ethicon Llc | Electrical ablation devices and methods |
US10278761B2 (en) | 2011-02-28 | 2019-05-07 | Ethicon Llc | Electrical ablation devices and methods |
US10314649B2 (en) | 2012-08-02 | 2019-06-11 | Ethicon Endo-Surgery, Inc. | Flexible expandable electrode and method of intraluminal delivery of pulsed power |
US10314603B2 (en) | 2008-11-25 | 2019-06-11 | Ethicon Llc | Rotational coupling device for surgical instrument with flexible actuators |
US10342598B2 (en) | 2012-08-15 | 2019-07-09 | Ethicon Llc | Electrosurgical system for delivering a biphasic waveform |
US10478248B2 (en) | 2007-02-15 | 2019-11-19 | Ethicon Llc | Electroporation ablation apparatus, system, and method |
US10492880B2 (en) | 2012-07-30 | 2019-12-03 | Ethicon Llc | Needle probe guide |
US10779882B2 (en) | 2009-10-28 | 2020-09-22 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices |
US11399834B2 (en) | 2008-07-14 | 2022-08-02 | Cilag Gmbh International | Tissue apposition clip application methods |
US11484191B2 (en) | 2013-02-27 | 2022-11-01 | Cilag Gmbh International | System for performing a minimally invasive surgical procedure |
Families Citing this family (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002230842A1 (en) | 2000-10-30 | 2002-05-15 | The General Hospital Corporation | Optical methods and systems for tissue analysis |
US9295391B1 (en) | 2000-11-10 | 2016-03-29 | The General Hospital Corporation | Spectrally encoded miniature endoscopic imaging probe |
CA2519937C (en) | 2003-03-31 | 2012-11-20 | Guillermo J. Tearney | Speckle reduction in optical coherence tomography by path length encoded angular compounding |
JP2007526620A (en) | 2003-06-06 | 2007-09-13 | ザ・ジェネラル・ホスピタル・コーポレイション | Wavelength tuning source device and method |
EP2270448B1 (en) | 2003-10-27 | 2020-03-18 | The General Hospital Corporation | Method and apparatus for performing optical imaging using frequency-domain interferometry |
AU2005270037B2 (en) | 2004-07-02 | 2012-02-09 | The General Hospital Corporation | Endoscopic imaging probe comprising dual clad fibre |
US8081316B2 (en) | 2004-08-06 | 2011-12-20 | The General Hospital Corporation | Process, system and software arrangement for determining at least one location in a sample using an optical coherence tomography |
JP5324095B2 (en) | 2004-08-24 | 2013-10-23 | ザ ジェネラル ホスピタル コーポレイション | Method and apparatus for imaging blood vessel segments |
WO2006024014A2 (en) | 2004-08-24 | 2006-03-02 | The General Hospital Corporation | Process, system and software arrangement for measuring a mechanical strain and elastic properties of a sample |
KR101257100B1 (en) | 2004-09-29 | 2013-04-22 | 더 제너럴 하스피탈 코포레이션 | System and Method for Optical Coherence Imaging |
EP1875436B1 (en) | 2005-04-28 | 2009-12-09 | The General Hospital Corporation | Evaluation of image features of an anatomical structure in optical coherence tomography images |
WO2006130802A2 (en) | 2005-06-01 | 2006-12-07 | The General Hospital Corporation | Apparatus, method and system for performing phase-resolved optical frequency domain imaging |
WO2007019574A2 (en) | 2005-08-09 | 2007-02-15 | The General Hospital Corporation | Apparatus, methods and storage medium for performing polarization-based quadrature demodulation in optical coherence tomography |
PL1937137T3 (en) | 2005-09-29 | 2022-11-21 | General Hospital Corporation | Method and apparatus for optical imaging via spectral encoding |
US9087368B2 (en) | 2006-01-19 | 2015-07-21 | The General Hospital Corporation | Methods and systems for optical imaging or epithelial luminal organs by beam scanning thereof |
WO2007084903A2 (en) | 2006-01-19 | 2007-07-26 | The General Hospital Corporation | Apparatus for obtaining information for a structure using spectrally-encoded endoscopy techniques and method for producing one or more optical arrangements |
EP2659852A3 (en) | 2006-02-01 | 2014-01-15 | The General Hospital Corporation | Apparatus for applying a plurality of electro-magnetic radiations to a sample |
JP5524487B2 (en) | 2006-02-01 | 2014-06-18 | ザ ジェネラル ホスピタル コーポレイション | A method and system for emitting electromagnetic radiation to at least a portion of a sample using a conformal laser treatment procedure. |
WO2007092911A2 (en) | 2006-02-08 | 2007-08-16 | The General Hospital Corporation | Methods, arrangements and systems for obtaining information associated with an anatomical sample using optical microscopy |
JP2009527770A (en) | 2006-02-24 | 2009-07-30 | ザ ジェネラル ホスピタル コーポレイション | Method and system for performing angle-resolved Fourier domain optical coherence tomography |
EP2015669A2 (en) | 2006-05-10 | 2009-01-21 | The General Hospital Corporation | Processes, arrangements and systems for providing frequency domain imaging of a sample |
US8838213B2 (en) | 2006-10-19 | 2014-09-16 | The General Hospital Corporation | Apparatus and method for obtaining and providing imaging information associated with at least one portion of a sample, and effecting such portion(s) |
EP2132840A2 (en) | 2007-03-23 | 2009-12-16 | The General Hospital Corporation | Methods, arrangements and apparatus for utlizing a wavelength-swept laser using angular scanning and dispersion procedures |
US10534129B2 (en) | 2007-03-30 | 2020-01-14 | The General Hospital Corporation | System and method providing intracoronary laser speckle imaging for the detection of vulnerable plaque |
EP2173254A2 (en) | 2007-07-31 | 2010-04-14 | The General Hospital Corporation | Systems and methods for providing beam scan patterns for high speed doppler optical frequency domain imaging |
US8861910B2 (en) | 2008-06-20 | 2014-10-14 | The General Hospital Corporation | Fused fiber optic coupler arrangement and method for use thereof |
EP2309923B1 (en) | 2008-07-14 | 2020-11-25 | The General Hospital Corporation | Apparatus and methods for color endoscopy |
EP2359121A4 (en) | 2008-12-10 | 2013-08-14 | Gen Hospital Corp | Systems, apparatus and methods for extending imaging depth range of optical coherence tomography through optical sub-sampling |
EP2389093A4 (en) | 2009-01-20 | 2013-07-31 | Gen Hospital Corp | Endoscopic biopsy apparatus, system and method |
CN101566630A (en) * | 2009-02-19 | 2009-10-28 | 浙江海洋学院 | Prewarning method for miichthys spotted maigre bacterial gill-rot disease |
WO2010105197A2 (en) | 2009-03-12 | 2010-09-16 | The General Hospital Corporation | Non-contact optical system, computer-accessible medium and method for measuring at least one mechanical property of tissue using coherent speckle techniques(s) |
CN102469943A (en) | 2009-07-14 | 2012-05-23 | 通用医疗公司 | Apparatus, systems and methods for measuring flow and pressure within a vessel |
JP5819864B2 (en) | 2010-03-05 | 2015-11-24 | ザ ジェネラル ホスピタル コーポレイション | System, method and computer accessible medium for providing a fine image of at least one anatomical structure at a specific resolution |
US9069130B2 (en) | 2010-05-03 | 2015-06-30 | The General Hospital Corporation | Apparatus, method and system for generating optical radiation from biological gain media |
EP2575598A2 (en) | 2010-05-25 | 2013-04-10 | The General Hospital Corporation | Apparatus, systems, methods and computer-accessible medium for spectral analysis of optical coherence tomography images |
EP2575597B1 (en) | 2010-05-25 | 2022-05-04 | The General Hospital Corporation | Apparatus for providing optical imaging of structures and compositions |
JP6066901B2 (en) | 2010-06-03 | 2017-01-25 | ザ ジェネラル ホスピタル コーポレイション | Method for apparatus and device for imaging structures in or in one or more luminal organs |
WO2012058381A2 (en) | 2010-10-27 | 2012-05-03 | The General Hospital Corporation | Apparatus, systems and methods for measuring blood pressure within at least one vessel |
WO2013013049A1 (en) | 2011-07-19 | 2013-01-24 | The General Hospital Corporation | Systems, methods, apparatus and computer-accessible-medium for providing polarization-mode dispersion compensation in optical coherence tomography |
US10241028B2 (en) | 2011-08-25 | 2019-03-26 | The General Hospital Corporation | Methods, systems, arrangements and computer-accessible medium for providing micro-optical coherence tomography procedures |
EP2769491A4 (en) | 2011-10-18 | 2015-07-22 | Gen Hospital Corp | Apparatus and methods for producing and/or providing recirculating optical delay(s) |
CN103131761A (en) * | 2011-12-01 | 2013-06-05 | 汕头大学医学院 | Molecular biology method of identifying black sea bream |
CN103131762A (en) * | 2011-12-01 | 2013-06-05 | 汕头大学医学院 | Molecular biological method of identifying rhabdosargus sarba |
CN103131759A (en) * | 2011-12-01 | 2013-06-05 | 汕头大学医学院 | Molecular biological method of identifying sparus latus |
CN103131763A (en) * | 2011-12-01 | 2013-06-05 | 汕头大学医学院 | Molecular biological method of identifying red porgy |
CN103131764A (en) * | 2011-12-01 | 2013-06-05 | 汕头大学医学院 | Molecular biology method of identifying priacanthus macracanthus |
CN103131766A (en) * | 2011-12-02 | 2013-06-05 | 汕头大学医学院 | Molecular biological method of identifying lateolabrax japonicus |
CN103131769A (en) * | 2011-12-02 | 2013-06-05 | 汕头大学医学院 | Molecular biological method of identifying trachinotus ovatus |
CN103131768A (en) * | 2011-12-02 | 2013-06-05 | 汕头大学医学院 | Molecular biological method of identifying nemipterus virgatus |
CN103131765A (en) * | 2011-12-02 | 2013-06-05 | 汕头大学医学院 | Molecular biological method of identifying silver pomfret |
EP2833776A4 (en) | 2012-03-30 | 2015-12-09 | Gen Hospital Corp | Imaging system, method and distal attachment for multidirectional field of view endoscopy |
US11490797B2 (en) | 2012-05-21 | 2022-11-08 | The General Hospital Corporation | Apparatus, device and method for capsule microscopy |
EP2948758B1 (en) | 2013-01-28 | 2024-03-13 | The General Hospital Corporation | Apparatus for providing diffuse spectroscopy co-registered with optical frequency domain imaging |
WO2014120791A1 (en) | 2013-01-29 | 2014-08-07 | The General Hospital Corporation | Apparatus, systems and methods for providing information regarding the aortic valve |
JP6378311B2 (en) | 2013-03-15 | 2018-08-22 | ザ ジェネラル ホスピタル コーポレイション | Methods and systems for characterizing objects |
EP2997354A4 (en) | 2013-05-13 | 2017-01-18 | The General Hospital Corporation | Detecting self-interefering fluorescence phase and amplitude |
EP3692887B1 (en) | 2013-07-19 | 2024-03-06 | The General Hospital Corporation | Imaging apparatus which utilizes multidirectional field of view endoscopy |
WO2015010133A1 (en) | 2013-07-19 | 2015-01-22 | The General Hospital Corporation | Determining eye motion by imaging retina. with feedback |
EP3910282B1 (en) | 2013-07-26 | 2024-01-17 | The General Hospital Corporation | Method of providing a laser radiation with a laser arrangement utilizing optical dispersion for applications in fourier-domain optical coherence tomography |
JP5662530B2 (en) * | 2013-08-12 | 2015-01-28 | 日清食品ホールディングス株式会社 | Primer and specific animal detection method |
WO2015105870A1 (en) | 2014-01-08 | 2015-07-16 | The General Hospital Corporation | Method and apparatus for microscopic imaging |
US10736494B2 (en) | 2014-01-31 | 2020-08-11 | The General Hospital Corporation | System and method for facilitating manual and/or automatic volumetric imaging with real-time tension or force feedback using a tethered imaging device |
US10228556B2 (en) | 2014-04-04 | 2019-03-12 | The General Hospital Corporation | Apparatus and method for controlling propagation and/or transmission of electromagnetic radiation in flexible waveguide(s) |
US10912462B2 (en) | 2014-07-25 | 2021-02-09 | The General Hospital Corporation | Apparatus, devices and methods for in vivo imaging and diagnosis |
CN114058710A (en) * | 2020-07-30 | 2022-02-18 | 中国科学院海洋研究所 | Method for identifying germ cell chimera of marine fish germ cell interspecific transplantation |
CN113173988B (en) * | 2021-04-15 | 2022-10-11 | 中国科学院水生生物研究所 | Preparation method of polyclonal antibody capable of marking fish reproductive stem cells |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002029064A2 (en) | 2000-10-02 | 2002-04-11 | Mermaid Pharmaceuticals Gmbh | Method for establishing germ cell-specific gene expression |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4300287B2 (en) * | 2002-02-14 | 2009-07-22 | 国立大学法人東京海洋大学 | Induction of germ line differentiation by transplantation of isolated primordial germ cells |
JP4670039B2 (en) * | 2004-09-30 | 2011-04-13 | 国立大学法人九州大学 | Apolipoprotein E gene polymorphism detection method |
JP2006333762A (en) | 2005-06-01 | 2006-12-14 | Mitsubishi Chemicals Corp | EXPRESSION VECTOR HAVING PROMOTER SEQUENCE OF MAMMAL-DERIVED Vasa HOMOLOG GENE AND ITS USE |
-
2008
- 2008-03-26 US US12/532,304 patent/US8222385B2/en active Active
- 2008-03-26 JP JP2008080789A patent/JP5509417B2/en active Active
- 2008-03-26 WO PCT/JP2008/000743 patent/WO2008129838A1/en active Application Filing
- 2008-03-26 EP EP08720622A patent/EP2133423B1/en active Active
- 2008-03-26 MX MX2009010331A patent/MX2009010331A/en active IP Right Grant
- 2008-03-26 ES ES08720622T patent/ES2401724T3/en active Active
- 2008-03-26 KR KR1020097019462A patent/KR20100014457A/en not_active Application Discontinuation
- 2008-03-26 AU AU2008241974A patent/AU2008241974B2/en active Active
-
2009
- 2009-09-24 IL IL201182A patent/IL201182A0/en unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002029064A2 (en) | 2000-10-02 | 2002-04-11 | Mermaid Pharmaceuticals Gmbh | Method for establishing germ cell-specific gene expression |
Non-Patent Citations (18)
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10478248B2 (en) | 2007-02-15 | 2019-11-19 | Ethicon Llc | Electroporation ablation apparatus, system, and method |
US11399834B2 (en) | 2008-07-14 | 2022-08-02 | Cilag Gmbh International | Tissue apposition clip application methods |
US20110244485A1 (en) * | 2008-09-25 | 2011-10-06 | National University Corporation Tokyo University Of Marine Science And Technology | Anti-tuna vasa antibody |
US10314603B2 (en) | 2008-11-25 | 2019-06-11 | Ethicon Llc | Rotational coupling device for surgical instrument with flexible actuators |
US10779882B2 (en) | 2009-10-28 | 2020-09-22 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices |
US10278761B2 (en) | 2011-02-28 | 2019-05-07 | Ethicon Llc | Electrical ablation devices and methods |
US10258406B2 (en) | 2011-02-28 | 2019-04-16 | Ethicon Llc | Electrical ablation devices and methods |
US11284918B2 (en) | 2012-05-14 | 2022-03-29 | Cilag GmbH Inlernational | Apparatus for introducing a steerable camera assembly into a patient |
US10206709B2 (en) | 2012-05-14 | 2019-02-19 | Ethicon Llc | Apparatus for introducing an object into a patient |
US10492880B2 (en) | 2012-07-30 | 2019-12-03 | Ethicon Llc | Needle probe guide |
US10314649B2 (en) | 2012-08-02 | 2019-06-11 | Ethicon Endo-Surgery, Inc. | Flexible expandable electrode and method of intraluminal delivery of pulsed power |
US10342598B2 (en) | 2012-08-15 | 2019-07-09 | Ethicon Llc | Electrosurgical system for delivering a biphasic waveform |
US11484191B2 (en) | 2013-02-27 | 2022-11-01 | Cilag Gmbh International | System for performing a minimally invasive surgical procedure |
Also Published As
Publication number | Publication date |
---|---|
KR20100014457A (en) | 2010-02-10 |
AU2008241974B2 (en) | 2013-09-12 |
EP2133423B1 (en) | 2013-01-09 |
AU2008241974A1 (en) | 2008-10-30 |
US20100132056A1 (en) | 2010-05-27 |
EP2133423A1 (en) | 2009-12-16 |
IL201182A0 (en) | 2011-08-01 |
JP2008263967A (en) | 2008-11-06 |
WO2008129838A1 (en) | 2008-10-30 |
EP2133423A4 (en) | 2010-04-07 |
MX2009010331A (en) | 2009-10-16 |
JP5509417B2 (en) | 2014-06-04 |
ES2401724T3 (en) | 2013-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8222385B2 (en) | Germ cell marker using fish vasa gene | |
Nagasawa et al. | cDNA cloning and expression analysis of a vasa-like gene in Pacific bluefin tuna Thunnus orientalis | |
US7163795B2 (en) | Methods and compositions for pearl oyster cultivation | |
EP1921145A1 (en) | RICE BLAST DISEASE GENE Pi21, RESISTANCE GENE pi21 AND UTILIZATION THEREOF | |
JP2014519320A (en) | Detection of saxitoxin-producing dinoflagellates | |
Cowan et al. | Genetic, genomic, and functional analysis of the granule lattice proteins in Tetrahymena secretory granules | |
US20110244485A1 (en) | Anti-tuna vasa antibody | |
EP1108786B1 (en) | Novel collectin | |
Zeng et al. | Cloning of Salt Tolerance‐Related cDNAs from the Mangrove Plant Sesuvium portulacastrum L. | |
JP5408802B2 (en) | Separation method for immature fish germ cells using surface immature germ cell specific protein | |
CN110809627A (en) | Optimized lentiviral vectors for XLA gene therapy | |
US6933375B2 (en) | mcFP encoding nucleic acids, polypepetides, antibodies and methods of use thereof | |
JP2013039056A (en) | Method and kit for determining mushroom cultivation period | |
Matthews et al. | Molecular characterization of a soybean cyst nematode (Heterodera glycines) homolog of unc-87 | |
CN111088266B (en) | Monoclonal antibody and kit for liver cancer cell transfer detection | |
CN111849997B (en) | Macrobrachium carinicauda compound eye development regulation gene and guide RNA as well as acquisition and application | |
JP2007236356A (en) | Structural gene of seashell of pearl oyster or pearl | |
KR101771291B1 (en) | Novel rice stripe with high productivity of rice seed and Process for preparing the same | |
JP2006262726A (en) | Carbonic anhydrase gene of common oyster | |
Kinlein | Genetic and Functional Studies of the Evolutionarily Oldest Natural Killer Receptor, NKp30 | |
WO2017164391A1 (en) | Marker for identifying germ cells having engraftability at host gonad | |
CN118684754A (en) | Cryptoanthocyanidin gene of migratoria manihot and encoding protein and application thereof | |
CN116874577A (en) | Application of Myb transcription factor gene in regulation and control of resistance of spodoptera frugiperda to Vip3A protein | |
EA014986B1 (en) | VASCULAR PLANTS WITH IMPROVED TOLERANCE TO NaAND METHOD OF IMPROVING | |
Park et al. | Identification and Expression Study of aXenopusHomologue of Prenylated SNARE Gene |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: NIPPON SUISAN KAISHA, LTD., JAPAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:YOSHIZAKI, GORO;TAKEUCHI, YUTAKA;NAGASAWA, KAZUE;AND OTHERS;REEL/FRAME:023948/0672 Effective date: 20091217 Owner name: NATIONAL UNIVERSITY CORPORATION TOKYO UNIVERSITY O Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:YOSHIZAKI, GORO;TAKEUCHI, YUTAKA;NAGASAWA, KAZUE;AND OTHERS;REEL/FRAME:023948/0672 Effective date: 20091217 |
|
AS | Assignment |
Owner name: NATIONAL UNIVERSITY CORPORATION TOKYO UNIVERSITY O Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE THE INVENTOR'S NAME ON THE NOTICE OF RECORDATION OF ASSIGNMENT DOCUMENT SHOULD BE CORRECTED FROM MORTIA TO MORITA PREVIOUSLY RECORDED ON REEL 023948 FRAME 0672. ASSIGNOR(S) HEREBY CONFIRMS THE PAGE 2 OF 2 - INVENTOR TETSURO MORITA;ASSIGNORS:YOSHIZAKI, GORO;TAKEUCHI, YUTAKA;NAGASAWA, KAZUE;AND OTHERS;REEL/FRAME:024198/0477 Effective date: 20091217 Owner name: NIPPON SUISAN KAISHA, LTD., JAPAN Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE THE INVENTOR'S NAME ON THE NOTICE OF RECORDATION OF ASSIGNMENT DOCUMENT SHOULD BE CORRECTED FROM MORTIA TO MORITA PREVIOUSLY RECORDED ON REEL 023948 FRAME 0672. ASSIGNOR(S) HEREBY CONFIRMS THE PAGE 2 OF 2 - INVENTOR TETSURO MORITA;ASSIGNORS:YOSHIZAKI, GORO;TAKEUCHI, YUTAKA;NAGASAWA, KAZUE;AND OTHERS;REEL/FRAME:024198/0477 Effective date: 20091217 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1552); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 8 |
|
AS | Assignment |
Owner name: NIPPON SUISAN KAISHA, LTD., JAPAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NATIONAL UNIVERSITY CORPORATION TOKYO UNIVERSITY OF MARINE SCIENCE AND TECHNOLOGY;REEL/FRAME:052092/0675 Effective date: 20200306 |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 12TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1553); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 12 |